Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
AUTOR(ES)
Chua, W
FONTE
Nature Publishing Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2743363Documentos Relacionados
- Effect of FOLFOX6 chemotherapy on serum VEGF expression in advanced colorectal cancer patients
- Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
- Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy
- Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancerpatients
- Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer